IDEXX Laboratories, Inc. (LON:0J8P)
753.62
+20.93 (2.86%)
At close: Nov 24, 2025
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $1.11B USD in the quarter ending September 30, 2025, with 13.29% growth. This brings the company's revenue in the last twelve months to $4.17B, up 8.39% year-over-year. In the year 2024, IDEXX Laboratories had annual revenue of $3.90B with 6.46% growth.
Revenue (ttm)
$4.17B
Revenue Growth
+8.39%
P/S Ratio
14.79
Revenue / Employee
$378.86K
Employees
11,000
Market Cap
45.85B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.90B | 236.55M | 6.46% |
| Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
| Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
| Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
| Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
| Dec 31, 2019 | 2.41B | 193.67M | 8.75% |
| Dec 31, 2018 | 2.21B | 244.18M | 12.40% |
| Dec 31, 2017 | 1.97B | 193.64M | 10.91% |
| Dec 31, 2016 | 1.78B | 173.53M | 10.83% |
| Dec 31, 2015 | 1.60B | 116.09M | 7.81% |
| Dec 31, 2014 | 1.49B | 108.75M | 7.90% |
| Dec 31, 2013 | 1.38B | 83.72M | 6.47% |
| Dec 31, 2012 | 1.29B | 74.65M | 6.13% |
| Dec 31, 2011 | 1.22B | 115.30M | 10.45% |
| Dec 31, 2010 | 1.10B | 71.76M | 6.96% |
| Dec 31, 2009 | 1.03B | 7.60M | 0.74% |
| Dec 31, 2008 | 1.02B | 101.48M | 11.00% |
| Dec 31, 2007 | 922.56M | 183.44M | 24.82% |
| Dec 31, 2006 | 739.12M | 101.02M | 15.83% |
| Dec 31, 2005 | 638.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
IDEXX Laboratories News
- 3 days ago - Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years - Benzinga
- 12 days ago - Baron Asset Fund Q3 2025 Performance Review - Seeking Alpha
- 18 days ago - Agree To Buy Idexx Laboratories At $600, Earn 5.3% Annualized Using Options - Nasdaq
- 20 days ago - IDXX Quantitative Stock Analysis - Nasdaq
- 20 days ago - IDEXX Laboratories (IDXX) Sees Target Price Raised by Morgan Stanley | IDXX Stock News - GuruFocus
- 20 days ago - 3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX) - Nasdaq
- 20 days ago - IDXX: JP Morgan Raises Price Target to $775, Maintains Overweight Rating | IDXX Stock News - GuruFocus
- 21 days ago - IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects - Seeking Alpha